Miyako Capital
VC Fund
Kyoto, Japan
Miyako Capital is a VC fund in Kyoto focused on Medical and Biotechnology. Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services. 2) Agri-Food: Industrialization, agricultural and fishery products growth-promoting technology, specified health food, health food. 3) Environment, Energy: Alternative energy, and related technologies. 4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot. 5) New services utilizing state-of-art technology. Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
- Total investments:
- 54
- Last investment:
- Lead investor:
- 19%
- Fund size:
- $91M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Miyako Capital invests in
Stages Miyako Capital invests in
Countries Miyako Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 6 contacts → | |||
Round size
- Seed
- $395k–$19M
- Series A
- $2M–$21M
- Series B
- $3.7M–$150M
Investment Focus
Industry
- Medical 12 (22%)
- Biotechnology 12 (22%)
- Information Technology 8 (15%)
- Health Care 7 (13%)
- Software 6 (11%)
Stage
- Series A 13 (24%)
- Seed 11 (20%)
- Series B 9 (17%)
- Venture - Series Unknown 6 (11%)
- Series C 5 (9%)
Country
- Japan 36 (67%)
- United States 4 (7%)
- United Kingdom 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
He Rui
Principle
|
Principle | Total investments: 1 | Find email | |
Hiroaki Okahashi
Co-Partner & Co-Founder
|
Co-Partner & Co-Founder | Total investments: 7 | Find email | |
|
Junko Sugaya
Director and Partner
|
Director and Partner | Total investments: 1 | Find email | |
Satoshi Yamaguchi
Co-Partner & Co-Founder
|
Co-Partner & Co-Founder | Total investments: 0 | Find email | |
Sunny Sugaya
Managing Director
|
Managing Director | Total investments: 2 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| United Immunity is a research, development, manufacture and sale of pharmaceuticals, mainly for cancer immunotherapy. | $11.3M / Venture - Series Unknown / Sep 24, 2026 | ||
| Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption. | $13.6M / Series A / Aug 29, 2025 | ||
| Mui is an aesthetically-pleasing wooden IoT device connected to a cloud service. By accessing information through natural wood, we can rethink a new type of lifestyle. | Series B / Aug 07, 2025 | ||
| xFOREST Therapeutics develops a drug discovery platform that targets RNA structures. | $6.1M / Series A / Jan 24, 2025 | ||
| Oishii Farm provides indoor vertical farming technology. Oishii sells via supermarkets, offering a container of between eight and 11 strawberries for $50 per package. Hiroki Koga and Brendan Somerville started the company in 2017. | $19.5M / Series B / Dec 17, 2024 | ||
| Peds3 is a digital healthcare platform that specializes in the research and development of pediatric medicine and maternal and child health fields. | $750.5K / Seed / Oct 02, 2024 | ||
| Innovative Space Carrier is a aerospace company that offers space transportation systems, planning, drafting and technology strategies. | $2.5M / Seed / Sep 10, 2024 | ||
| Sakana AI creates a new kind of foundation model based on nature-inspired intelligence. | $209.3M / Series A / Sep 04, 2024 | ||
| Orange is a developer of a variety of deep-learning models with a focus on computer vision and natural language processing for comics. | $19M / Seed / May 06, 2024 | ||
| Oishii Farm provides indoor vertical farming technology. Oishii sells via supermarkets, offering a container of between eight and 11 strawberries for $50 per package. Hiroki Koga and Brendan Somerville started the company in 2017. | $150M / Series B / Feb 27, 2024 | ||
| See all 54 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Miyako Capital invest in?
Miyako Capital invests primarily in Medical, Biotechnology and Information Technology startups, most often at Series A and Seed stage. Most of the 54 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Miyako Capital invest in?
Miyako Capital typically joins rounds of $395k–$19M at Seed, $2M–$21M at Series A and $3.7M–$150M at Series B. These are whole funding-round sizes, not Miyako Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Miyako Capital took part in.
How do I contact Miyako Capital?
Public channels for Miyako Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Miyako Capital?
The team at Miyako Capital includes He Rui (Principle), Hiroaki Okahashi (Co-Partner & Co-Founder) and Junko Sugaya (Director and Partner), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
